Seattle Genetics Inc., a developer of anti-cancer drugs based in south Snohomish County, is the fastest-growing technology firm in the state, according to Deloitte’s annual Fast 50 list.
Four other companies in the county, including three in Bothell, also ranked on the list.
Seattle Genetics, which also has its headquarters in Bothell, saw revenues grow by 6,669 percent during the past five years. For comparison, the No. 2 company on the list, Seattle’s Cell Therapeutics, recorded revenue growth of 5,867 percent.
“What this acknowledges is we’ve got very good revenue trends. But we don’t lose track of our main goal,” said Clay Siegall, Seattle Genetics’ chief executive officer.
That goal is to develop an array of drugs to fight cancers, most of which use the company’s patented antibody-drug conjugate technology to more finely target tumor cells.
The company’s most advanced drug, SGN-30, is in phase 2 tests against malignancies such as Hodgkin’s disease
Other local companies that ranked on the Fast 50 list were Mortage Investment Lending Associates Inc., a private lending firm based in Mountlake Terrace. It was No. 12 with revenue growth of 872 percent.
SonoSite Inc. of Bothell, the maker of portable ultrasound systems, was No. 20, with revenues increasing by 262 percent over the past five years. Diagnostic Ultrasound Corp. and Quinton Cardiology, which recently merged to become Cardiac Science, ranked 33rd and 35th, respectively.
Reporter Eric Fetters: 425-339-3453 or fetters@heraldnet.com.
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.
